Ayahuasca Afterglow — How Post-Trip Mindfulness May Play A Part In Treating Depression

At the center of the new psychedelic renaissance is an Amazonian tea called ayahuasca, which contains dimethyltryptamine or DMT, one of the most powerful hallucinogens known to science. Traditionally brewed by indigenous shamans in places like Peru and Brazil, ayahuasca is gaining more mainstream appeal for its purported use in treating addiction, treatment-resistant depression and […]

Continue Reading

Beyond Materialism: Interview with Rita Kočárová about International Transpersonal Conference 2017

As humanity sits on the cusp of a new paradigm that moves beyond strict materialism and into a holistic understanding that includes subtle forces and the subjective experience, we find ourselves needing to have new conversations that bring together multiple disciplines to achieve a higher order of understanding. While this sounds like a lofty undertaking, […]

Continue Reading

MAPS Now Accepts Bitcoin—Plus, Other Ways You Can Support Psychedelic Research

  The Multidisciplinary Association for Psychedelic Studies (MAPS) is now accepting your favorite cryptocurrencies—Bitcoin, Ethereum and even Litecoin. Since their start in 1986, MAPS has been a world leader for advancing psychedelic research, piloting studies on everything from LSD to ibogaine to cannabis to DMT. Adding cryptocurrency to their list of accepted donations will allow […]

Continue Reading

New Psilocybin Review: It’s Safe, Highly Effective and Begs Further Study

  A recent clinical review of psilocybin, the active compound in “magic mushrooms”, shows that it holds great promise in treating psychiatric conditions such as anxiety, depression, and substance abuse. This review of seven independent studies, authored by Kelan Thomas of Toura University California and published in the peer-reviewed Journal of Psychoactive Drugs, highlights both […]

Continue Reading

The Legendary Psychedelic Symposium Returns at ESPD50: Interview with Dennis McKenna

  In January 1967 ethnobotanists and neuroscientists gathered together in San Francisco, California to discuss the exotic psychedelic substances that explorers were finding in use in indigenous cultures around the world. The Ethnopharmacologic Search for Psychoactive Drugs (ESPD) was the first psychedelic conference of its kind and was funded by the US government, happening just […]

Continue Reading